Vivatech 2023

France

ALSYMO

Health
Against pulmonary arterial hypertension, ALSYMO develops a first-in-class drug candidate: it is a patented peripheral NMDA receptor antagonist able to inhibit the thickening of blood vessels, at the origin of the increase in blood pressure in the lungs.
Deep Tech
Healthcare & Wellness

More info

CREATION

2022

EMPLOYEES

1-5

CITY

Le Kremlin-Bicetre

DEVELOPMENT LEVEL

Conception stage

LOOKING FOR

Funding


Hosted By

Media gallery

URL DE LA  VIDEO DE PRESENTATION

DATES / SEE ALL / MENUS / SESSIONS

GTM